Skip to content

Tornier Blueprint Planning Software in Patients Receiving Reverse Shoulder Arthroplasty

A Single-arm, Prospective Study of Tornier Blueprint Planning Software in Patients Receiving Reverse Shoulder Arthroplasty

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04474665
Enrollment
20
Registered
2020-07-17
Start date
2020-03-16
Completion date
2021-06-01
Last updated
2020-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Reverse Shoulder Replacement

Brief summary

Compare sizing determined in pre-operative planning of reverse shoulder arthroplasty to operative implant size selected.

Detailed description

The Blueprint planning software automatically creates a virtual implantation environment for the surgeon to use. The use of 3D measurements is independent of patient positioning, which results in more accurate measurements of the glenoid version and inclination measurements in shoulder replacement surgery. Pre-operative planning with Blueprint can accurately predict intraoperative implant selection within one size. Also, pre-operative planning leads to case efficiency and improved functional outcomes at 6 months post-operative compared to Baseline. The objective of this study is to characterize implant size accuracy, planning time, functional outcomes, and procedural time (i.e., surgical time) using Blueprint planning software in subjects who are candidates for reverse shoulder arthroplasty.

Interventions

DEVICEReverse shoulder arthroplasty utilizing Blueprint Software

Reverse shoulder arthroplasty utilizing Blueprint Software

Sponsors

Stryker Trauma and Extremities
CollaboratorINDUSTRY
Spine Institute of Louisiana Foundation
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Skeletally mature, and age ≥ 18 years. 2. In the opinion of the treating surgeon, must already be a qualified candidate for reverse shoulder arthroplasty without the use of glenoid bone grafts. 3. Be likely to return for regular follow-ups until the end of the study period. 4. Be willing and able to provide Informed Consent for study participation.

Exclusion criteria

1. Previous bony surgery on the operative shoulder. 2. Shoulder pain due to acute trauma. 3. Clinical, laboratory and/or radiological evidence of shoulder pain secondary to acute or chronic infection, malignancy, other space occupying lesions and metabolic bone demineralization diseases (e.g. osteomalacia, gout, Paget's disease etc.) 4. Any active malignancy, infectious process, or documented chronic autoimmune disease. 5. Any other concurrent medical disease or treatment that might impair normal healing process. 6. Recent history (within past 6 months) of any chemical or alcohol dependence. 7. Currently a prisoner. 8. Currently experiencing a major mental illness (psychosis, schizophrenia, major affective disorder) which may indicate that the symptoms are psychological rather than of physical origin. 9. Pregnant or planning to become pregnant within study duration.

Design outcomes

Primary

MeasureTime frameDescription
Range of motion6 monthsRange of motion of the operative shoulder
Accuracy of sizingPerioperativeBlueprint planned implant size compared to actual implant size
Time to plan/perform casePre-operativeTime required for surgeon to plan and perform the case using the Bluerpint software

Secondary

MeasureTime frameDescription
American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form (ASES)12 weeksQuestionnaire to score and understand how well you function in everyday life, concerning your shoulder pain/limitations. 0-100 score, with higher score indicating higher functionality.
Simple Shoulder Test (SST) QuestionnairePre-operative12 yes/no questions to understand your daily functionality concerning your shoulder.
Patient Satisfaction12 weeksPatient rated satisfaction with surgical treatment rated; very satisfied, somewhat satisfied, somewhat dissatisfied, or very dissatisfied

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026